Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-105604
Filing Date
2025-11-04
Accepted
2025-11-04 07:15:44
Documents
2
Period of Report
2025-11-04

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0263614-6k_newcelx.htm 6-K 10263
2 PRESS RELEASE TITLED: "NEWCELX CEO ISSUES LETTER TO SHAREHOLDERS" ea026361401ex99-1_newcelx.htm EX-99.1 18327
  Complete submission text file 0001213900-25-105604.txt   29780
Mailing Address THE CIRCLE 6 8058 ZURICH Switzerland
Business Address THE CIRCLE 6 8058 ZURICH Switzerland 41-41-618-80-00
NewcelX Ltd. (Filer) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 251446439
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)